SG/CALL/ROCHE GS/240/0.1/21.06.24 Share Price

Warrant

DE000SW3YTR9

Delayed Deutsche Boerse AG 08:32:42 14/06/2024 pm IST
0.85 EUR +30.77% Intraday chart for SG/CALL/ROCHE GS/240/0.1/21.06.24
Current month+1,474.07%
1 month+1,018.42%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
14/24/14 0.85 +30.77%
13/24/13 0.65 +103.12%
12/24/12 0.32 0.00%
11/24/11 0.32 +6.67%
10/24/10 0.3 -26.83%

Delayed Quote Deutsche Boerse AG

Last update June 14, 2024 at 08:32 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Société Générale Société Générale
WKN SW3YTR
ISINDE000SW3YTR9
Date issued 26/09/2023
Strike 240 CHF
Maturity 21/06/2024 (4 Days)
Parity 10 : 1
Emission price 1.97
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 2.49
Lowest since issue 0.01
Delta0x
Omega 0.000000
Premium0x
Gearing0x
Moneyness 1.032
Difference Strike -5.5 CHF
Difference Strike %-2.29%
Intrinsic value 0.7971

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
247.6 CHF
Average target price
278.1 CHF
Spread / Average Target
+12.30%
Consensus